How to Treat My Non-Hodgkin Lymphoma: What are the Different Treatment Options?
The Patient Story founder Stephanie Chuang was diagnosed with Diffuse Large B-Cell Lymphoma at 31. Like many others, she was completely overwhelmed. After undergoing treatment she was able to reach remission. But throughout her cancer journey, she felt a great need for more options in treatment. She wanted to know, what are the treatments out there? What are the options? What should you be asking your doctor?
In this conversation, she speaks with Dr. Josh Brody, who leads the Lymphoma Immunotherapy Program at Mount Sinai and Dr. Lorenzo Falchi, an oncologist at Memorial Sloan Kettering Cancer Center with special research focus on immunotherapies for B-cell non-Hodgkin lymphoma. They discuss breakthrough therapies for DLBCL, immunotherapy and bispecific antibodies.
Special thanks to Genmab for its support of our patient education program!
Full story & transcript โ https://www.thepatientstory.co....m/medical-experts/dl
Join Our Community:
Website : https://www.thepatientstory.com/
Facebook: @ThePatientStory
Instagram: @ThePatientStory
Twitter: @patient_story
02:35- Immunotherapy for DBCL
04:34 - CAR-T cell therapy for DLBCL
05:54 - Bispecific Antibodies
10:12 - Deciding whether to give bispecific antibodies or car-t cell therapy
#cancersurvivor #cancerstories #cancer #thepatientstory #dlbcl #lymsm #nonhodgkinlymphoma #lymphoma #lymphomasurvivor #lymphomaawareness #cancertreatments #cancerresearch
-
Category
No comments found